GLP-1 Agonists and Fat-Loss Peptides
Quick Answer GLP-1 agonists and fat-loss peptides include FDA-approved drugs like semaglutide and tirzepatide alongside investigational compounds such as retatrutide, […]
GLP-1 & Fat Loss
GLP-1 & Fat Loss
GLP-1 & Fat Loss
5-Amino-1MQ: NNMT Inhibitor for Fat Loss (Not a Peptide)
Quick Answer 5-Amino-1MQ is a small-molecule NNMT inhibitor studied for fat loss and metabolic health, and despite turning up constantly
GLP-1 & Fat Loss
HGH Fragment 176-191: Fat Loss Evidence and Safety
Quick Answer HGH Fragment 176-191 is the unmodified fat-burning tail of human growth hormone and the parent sequence behind AOD-9604,
GLP-1 & Fat Loss
Orforglipron (Foundayo): The First Non-Peptide GLP-1 Pill
Quick Answer Orforglipron (brand name Foundayo) is a once-daily oral GLP-1 receptor agonist that the FDA approved on 1 April
GLP-1 & Fat Loss
AOD-9604: Fat Loss Peptide Evidence and Legal Status
Quick Answer AOD-9604 is a modified fragment of human growth hormone developed as an anti-obesity drug, but six human clinical
GLP-1 & Fat Loss
Retatrutide: The GIP/GLP-1/Glucagon Triple Agonist
Quick Answer Retatrutide is Eli Lilly’s investigational “triple agonist” that activates the GIP, GLP-1, and glucagon receptors at once, and
GLP-1 & Fat Loss
Tirzepatide Guide: The Dual GIP/GLP-1 Agonist Behind Mounjaro and Zepbound
Quick Answer Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist sold as Mounjaro (type 2 diabetes) and Zepbound (weight management
GLP-1 & Fat Loss
Semaglutide Guide: What It Is, How It Works, and What the Evidence Shows
Quick Answer Semaglutide is an FDA-approved GLP-1 receptor agonist sold as Ozempic (type 2 diabetes), Wegovy (weight management and cardiovascular